Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.

Major CRO Parexel has teamed up with tech giant Microsoft to create a new cloud tech alliance, all aimed at speeding up drug research.

Forge Therapeutics and Evotec have launched a discovery platform to develop novel antibiotics targeting metalloenzymes.

A full 14 years after founding CRO Clinipace, its long-standing CEO and president, Jeff Williams, is planning to step down.

U.K.-based trial services company Ergomed has penned a deal to buy PSR Group BV, a specialist orphan drug CRO, as it adds to its offerings.

Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.

Treos Bio has tapped PPD to manage its first-in-human study on its lead cancer vaccine for colorectal cancer.

A recent study by the Tufts Center for the Study of Drug Development found that EDC systems still aren't efficiently accelerating clinical trials.

Indivumed and Helomics have teamed up to advance research in personalized cancer treatments.